Zacks Investment Research on MSN
OraSure files for FDA review of molecular self-test & Colli-Pee device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...
Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...
Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.
The rapid molecular chlamydia and gonorrhea self-test provides results in 30 minutes from a self-collected swab sample, the firm said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback